We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00062660
Recruitment Status : Approved for marketing
First Posted : June 12, 2003
Last Update Posted : November 30, 2016
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Approved for marketing
  Primary Completion Date : April 2014
  Study Completion Date : April 2014